# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000875045-19-000029
Filing Date
2019-07-24
Accepted
2019-07-23 17:47:07
Documents
128
Period of Report
2019-06-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | biib-2019630x10q.htm iXBRL | 10-Q | 3828029
2 | EXHIBIT 10.1 | biib-2019630xex101.htm | EX-10.1 | 28981
3 | EXHIBIT 10.2 | biib-2019630xex102.htm | EX-10.2 | 33794
4 | EXHIBIT 10.3 | biib-2019630xex103.htm | EX-10.3 | 33280
5 | EXHIBIT 10.4 | biib-2019630xex104.htm | EX-10.4 | 61526
6 | EXHIBIT 31.1 | biib-2019630xex311.htm | EX-31.1 | 14188
7 | EXHIBIT 31.2 | biib-2019630xex312.htm | EX-31.2 | 14937
8 | EXHIBIT 32.1 | biib-2019630xex321.htm | EX-32.1 | 10781
14 |  | acquiredinprocessrd.jpg | GRAPHIC | 20815
15 |  | amortofintangibles.jpg | GRAPHIC | 23811
16 |  | anticd20.jpg | GRAPHIC | 46847
17 |  | biogenlogostandardrgbr.jpg | GRAPHIC | 95992
18 |  | biosimilars.jpg | GRAPHIC | 37396
19 |  | collabprofitshare.jpg | GRAPHIC | 23419
20 |  | costofsales.jpg | GRAPHIC | 34589
21 |  | equityinlossofinvestee.jpg | GRAPHIC | 19800
22 |  | financialhighlights.jpg | GRAPHIC | 37381
23 |  | gainlossonfvremeasure.jpg | GRAPHIC | 22294
24 |  | incometaxprovision.jpg | GRAPHIC | 35520
25 |  | interferon.jpg | GRAPHIC | 37879
26 |  | lossonassetheldforsale.jpg | GRAPHIC | 19377
27 |  | oie.jpg | GRAPHIC | 22404
28 |  | otherrevenues.jpg | GRAPHIC | 34060
29 |  | rd.jpg | GRAPHIC | 67105
30 |  | rdpercentofrev.jpg | GRAPHIC | 43571
31 |  | reservesdiscountsandallow.jpg | GRAPHIC | 39571
32 |  | sga.jpg | GRAPHIC | 24388
33 |  | spinraza.jpg | GRAPHIC | 36524
34 |  | tecfidera.jpg | GRAPHIC | 41120
35 |  | tysabri.jpg | GRAPHIC | 37777
| Complete submission text file | 0000875045-19-000029.txt |  | 18419326

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT | biib-20190630.xsd | EX-101.SCH | 72706
10 | XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT | biib-20190630_cal.xml | EX-101.CAL | 132535
11 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT | biib-20190630_def.xml | EX-101.DEF | 439421
12 | XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT | biib-20190630_lab.xml | EX-101.LAB | 1054609
13 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT | biib-20190630_pre.xml | EX-101.PRE | 651529
36 | EXTRACTED XBRL INSTANCE DOCUMENT | biib-2019630x10q_htm.xml | XML | 3768714

Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19311 | Film No.: 19968619
SIC: 2836 Biological Products, (No Diagnostic Substances)